IL6 and breast cancer: Currently, the research of natural compounds exhibiting antioxidant activity with few side effects has made the leap from research laboratories to the pharmaceutical industry, giving it greater importance in BC, because of the great involvement of the proinflammatory components, such as cytokines, (TNF-α and IL-6) that promote BC cell proliferation and metastasis [135].